Capsugel(R) DBcaps(R) Over-Encapsulation Capsule

Capsugel(R) DBcaps(R) Over-Encapsulation Capsule

Products
Capsugel(R) DBcaps(R) Over-Encapsulation Capsule
Capsugel(R) DBcaps(R) Over-Encapsulation Capsule

Information

DBcaps(R) Over-Encapsulation Capsules are developed with a tamper-evident and easy-to-swallow design to specifically address the clinical trial challenges without bias in double-blind tests. Available as gelatin or HPMC capsules.
All Categories
Capsules
Main Categories
Finished Dosage Forms (Products)
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Lonza Capsugel8.0S76Visit Lonza Capsugel at Zone Excipients, Hall 8, Stand 0.S76. We provide high-quality capsules and innovative solutions for oral drug delivery and inhalation. Our expertise supports the optimization of formulations, offering tailored technologies and services to advance pharmaceutical and nutraceutical development worldwide. Our global network includes complete supply chain, regulatory, quality and application support to meet your needs with capsule manufacturing facilities in North America, Europe, India, China and Japan. We offer full lifecycle development and manufacturing (CDMO) for oral and inhalation drug products.